Tranzme Pharma


Former Roche executive Abercrombie named to Tranzyme’s board

Former Roche executive George Abercrombie is joining the board of directors of Tranzyme Pharma (NASDAQ:TZYM). Durham, North Carolina-based Tranzyme, which focuses on gastrointestinal treatments, will tap the more than 30 years of experience of Abercrombie, who was president and CEO of Roche’s North American pharmaceuticals operations from 2001 through 2009. Tranzyme does not yet have […]